Navigation Links
PAREXEL and Salem State University Launch Clinical Trial Management Graduate Program
Date:9/20/2012

ice and biotechnology industry; consolidation within the pharmaceutical industry and competition within the biopharmaceutical services industry; the potential for significant liability to clients and third parties; the potential adverse impact of health care reform; and the effects of exchange rate fluctuations and other international economic, political, and other risks.
Such factors and others are discussed more fully in the section entitled "Risk Factors" of the Company's Annual Report on Form 10-K for the fiscal year ended June 30, 2012 as filed with the SEC on August 27, 2012, which "Risk Factors" discussion is incorporated by reference in this press release.  The Company specifically disclaims any obligation to update these forward-looking statements in the future.  These forward-looking statements should not be relied upon as representing the Company's estimates or views as of any date subsequent to the date of this press release.

PAREXEL is a registered trademark and PAREXEL MyTrials is a trademark of PAREXEL International Corporation and Perceptive Informatics is a trademark of Perceptive Informatics, Inc. All other names or marks may be registered trademarks or trademarks of PAREXEL International Corporation, Perceptive Informatics, Inc. or their respective owners and are hereby acknowledged. Contacts:Georgina Cattaway, Director Marketing

Kim Leadley/Sarah BrucknerPAREXEL International

PAN CommunicationsTel: +44 1895 614530

Tel: +1 617-502-4300Email: Georgina.Cattaway@PAREXEL.com

Email: PAREXEL@pancomm.com


'/>"/>
SOURCE PAREXEL International Corporation
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. PAREXEL Chief Operating Officer Dr. Mark A. Goldberg Receives Special Recognition Award
2. PAREXEL Reports Third Quarter Fiscal Year 2012 Financial Results
3. Parexel Invites Public To Listen To Live Webcast Of Its Investor Day May 31, 2012
4. PAREXEL Chairman And CEO To Ring The Bell At The NASDAQ Stock Market Opening
5. PAREXEL International Issues Earnings Guidance In Conjunction With Investor Day
6. PAREXEL International To Present At NASDAQ OMX Investor Conference
7. PAREXEL Announces Date of Fourth Quarter and Fiscal Year 2012 Earnings Release and Conference Call
8. PAREXEL And Korea Drug Development Fund Announce Alliance To Accelerate Global Drug Development And Commercialization
9. PAREXEL Launches The PAREXEL BioPharm Unit To Meet The Critical Development Goals Of Small And Mid-Sized Biopharmaceutical Companies
10. PAREXEL Strengthens Outcomes Research Capabilities To Help Biopharma Meet Commercialization Goals
11. PAREXEL International to Present at Robert Baird Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/30/2014)... -- Decision Resources Group finds that the markets for peripheral ... Russia , India ... see robust expansion as these economies expand and as ... revenues will be somewhat impeded by poor distribution of ... and demand for low-cost products, the market will ultimately ...
(Date:9/30/2014)... , Sept. 30, 2014  Decision Resources Group finds that the ... Australia , China , India ... at a strong rate through 2023. Dental implant procedure volumes will ... patient awareness rises. Other key findings from Decision Resources ... implant market: , Dental implant penetration: Penetration of ...
(Date:9/30/2014)... Sept. 30, 2014  According to their CEO, ... cancer clinical trials is going through a complete ... the work of the current clinical trial management ... ,next generation, clinical trials, which will ultimately drive ... The company has been recognized by the ...
Breaking Medicine Technology:Brazilian, Russian, Indian and Chinese Markets for Peripheral Vascular Devices Will See Strong Expansion Through 2023 2Brazilian, Russian, Indian and Chinese Markets for Peripheral Vascular Devices Will See Strong Expansion Through 2023 3Asia Pacific Dental Implant Market Will Grow at a Strong Rate Through 2023 2Asia Pacific Dental Implant Market Will Grow at a Strong Rate Through 2023 3Small Denver Company Pharmatech driving a large revolution in how cancer clinical trials are managed 2
... 2012  Based on its recent analysis of the ... recognizes Sensear with the 2012 North American Frost ... its "high-noise communication" devices, including earplugs and earmuffs ... still enabling the user to remain fully aware ...
... Carla Corkern, Chief Executive Officer at Talyst , was ... recognizes entrepreneurs whose ingenuity, hard work and perseverance have created ... originated in 1986 and has grown to 26 programs in ... the world. "Talyst is a leader in ...
Cached Medicine Technology:Frost & Sullivan Recognizes Sensear for Innovative and Effective Product Differentiation in the PPE Market 2Frost & Sullivan Recognizes Sensear for Innovative and Effective Product Differentiation in the PPE Market 3Frost & Sullivan Recognizes Sensear for Innovative and Effective Product Differentiation in the PPE Market 4
(Date:9/30/2014)... 2014 The American Diabetes Association ... diabetics curb their sweet tooth, but the most recent ... September, suggests that zero-calorie sweeteners may actually be linked ... , The Weizmann Institute of Science in Israel ... to mice, the mice developed glucose intolerance. They then ...
(Date:9/30/2014)... Regenerative Medicine Solutions (RMS) is set ... Nashville, Tennessee. RMS welcomes the launch of an entirely ... of a new treatment center for the Lung Institute. ... Institute to Nashville, the hope is to bring awareness ... diagnosed and undiagnosed. With Nashville being a hub for ...
(Date:9/30/2014)... Sept. 30, 2014 (HealthDay News) -- Medicare should cover ... high risk for the disease, a coalition of more ... coalition, which includes the Lung Cancer Alliance, the Society ... American Cancer Society and the American Society of Clinical ... to the U.S. Centers for Medicare & Medicaid Services ...
(Date:9/30/2014)... Healthcare advocates, patient navigators, healthcare providers and caregivers ... Consultants (#NAHAC) fifth annual conference, “Mastering the Power and ... 30th - Nov. 1st, 2014 in Chicago, Illinois. ... Practices for the Field of Healthcare Advocacy. As ... a set of standards and best practices. NAHAC stepped ...
(Date:9/30/2014)... (PRWEB) September 30, 2014 To mark ... Editorial Board of Living with a Disability magazine ... light on hematological disorders as disabling conditions. ... more than a diagnosis to establish a disability related ... thrombocytomenia, myelofibrosis, hereditary telangiectasia, coagulation defects, polycythemia vera, and ...
Breaking Medicine News(10 mins):Health News:Artificial Sweeteners May be Linked to Greater Diabetes Risk 2Health News:Regenerative Medicine Solutions Expanding 2Health News:Groups Call for Medicare Coverage of Lung Cancer Screening 2Health News:Living with a Disability Magazine Marks National Sickle Cell Health Month with New Article on Hematological Disorders 2Health News:Living with a Disability Magazine Marks National Sickle Cell Health Month with New Article on Hematological Disorders 3
... NAPA, Calif., Feb. 6 Senetek PLC (OTC,Bulletin ... the development,of technologies that target the science of ... new website; http://www.senetekplc.com ., Mr. Frank ... are pleased to bring greater visibility to Senetek ...
... to come, WASHINGTON, Feb. 6 Across five ... people and supplies,are flowing in to provide care to ... 5. In every tornado-affected,community, Red Cross workers are on ... rescue workers, and lending emotional support to,all., More ...
... are both highly effective in treating mild to moderately severe ... Medicine have found the first study to compare the ... skin disorder. , Peels using beta-hydroxy acid (or BHA) had ... longer than did peels using alpha-hydroxy acid (or AHA), the ...
... clinical trial involving the use of gene therapy in combination ... more effective than radiation therapy alone for patients with intermediate ... a $9 million grant from the National Cancer Institute (NCI) ... therapy to treat prostate cancer. , As part ...
... seek restatement of Beth Israel Deaconess,Medical Center audit, ... T. Linde should apply the same Sarbanes-Oxley,standards used by ... on the board of Beth Israel Deaconess Medical Center ... East. Linde is,also the president and CFO of Boston ...
... saving treatment option for people with end-stage liver disease. ... supply. Each year only about one-third of people who ... patients die while waiting. In the February issue of ... for allocating donor organs in the United States affects ...
Cached Medicine News:Health News:Senetek PLC Announces Launch of New Website 2Health News:Massive American Red Cross Tornado Relief Effort Spans Five States 2Health News:Treating acne: 2 different acid peels are both effective, study finds 2Health News:Henry Ford Hospital expands research on gene and radiation therapy for prostate cancer 2Health News:Henry Ford Hospital expands research on gene and radiation therapy for prostate cancer 3Health News:Boston Properties Executive and Board Member Should Use Sarbanes-Oxley Disclosure Rules in Non-Profit Role, Asserts 1199 SEIU 2Health News: Mayo Clinic Proceedings contributors discuss impact of donor organ allocation system 2Health News: Mayo Clinic Proceedings contributors discuss impact of donor organ allocation system 3
... Trappers are ideal for use with custom ... Finger Trappers' non-slip foam lining replaces fingernail ... in traction. These are truly the "No ... packages of 5 and boxes of 25. ...
One splint does it all....
... heavy duty, controlled stretch knee brace provides ... or for those individuals with a history ... metal bars provide excellent side-to-side support, yet ... The elastic sleeve supports the entire knee ...
... is a heavy duty, controlled stretch knee ... pain while allowing full range of motion. ... bend with the knee, and help to ... wearing comfort. This is an excellent ...
Medicine Products: